Auris Medical Holding Ltd. (NASDAQ: EARS) is 17.94% higher on its value in year-to-date trading and has touched a low of $0.72 and a high of $6.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EARS stock was last observed hovering at around $3.42 in the last trading session, with the day’s loss setting it -0.33% off its average median price target of $14.30 for the next 12 months. It is also 78.39% off the consensus price target high of $14.30 offered by 1 analysts, but current levels are 78.39% higher than the price target low of $14.30 for the same period.
Currently trading at $3.09, the stock is -18.83% and -12.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.13 million and changing -9.65% at the moment leaves the stock 62.46% off its SMA200. EARS registered 311.95% gain for a year compared to 6-month gain of 286.25%. The firm has a 50-day simple moving average (SMA 50) of $3.6964 and a 200-day simple moving average (SMA200) of $2.3543.
The stock witnessed a 9.96% loss in the last 1 month and extending the period to 3 months gives it a 17.94%, and is -8.58% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.52% over the week and 16.46% over the month.
Auris Medical Holding Ltd. (EARS) has around 12 employees, a market worth around $41.47M and $0.19M in sales. Distance from 52-week low is 327.57% and -53.18% from its 52-week high.
Auris Medical Holding Ltd. (EARS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Auris Medical Holding Ltd. (EARS) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Auris Medical Holding Ltd. is expected to release its quarterly report on 08/19/2021 and quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $59.1M over the same period..
Auris Medical Holding Ltd. (EARS) Top Institutional Holders
10 institutions hold shares in Auris Medical Holding Ltd. (EARS), with 569.87k shares held by insiders accounting for 4.43% while institutional investors hold 1.52% of the company’s shares. The shares outstanding are 13.42M, and float is at 12.61M with Short Float at 3.90%. Institutions hold 1.46% of the Float.
The top institutional shareholder in the company is Virtu Financial LLC with over 63920.0 shares valued at $0.17 million. The investor’s holdings represent 0.86% of the EARS Shares outstanding. As of Dec 30, 2020, the second largest holder is Renaissance Technologies, LLC with 63020.0 shares valued at $0.17 million to account for 0.85% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 21727.0 shares representing 0.29% and valued at over $56924.0, while Envestnet Asset Management holds 0.17% of the shares totaling 12450.0 with a market value of $32619.0.